Cytomegalovirus UL21-5 mRNAemia as a Marker of Active Virus Replication in Allogeneic Hematopoietic Transplant Recipients.

Prevymis (letermovir) - Merck (MSD)

Cytomegalovirus UL21-5 mRNAemia as a Marker of Active Virus Replication in Allogeneic Hematopoietic Transplant Recipients. (PubMed, J Med Virol) - Sep 23, 2025 - No abstract available
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Transplantation

http://www.ncbi.nlm.nih.gov/pubmed/40985324

Carlos Solano; Carlos Solano de la Asunción; Concepción Gimeno; David Navarro; Eliseo Albert; Estela Gimenez; Jose Luis Piñana; María Dolores Ocete

Sep 23, 2025